Earnings Breakdown: Ping An Insurance (2318) Reports YTD P&C Insurance Premium Income of 79.08B Yuan

Ping An Insurance (H) on Smartkarma

Analyst coverage on Ping An Insurance (H) by Brian Freitas on Smartkarma has shed light on a potential trend reversal. The A-shares of Ping An are currently trading at a significant premium compared to the H-shares, with a difference that has notably widened recently. Freitas suggests that this discrepancy could lead to a sharp reversal in the near future. The AH premium of Ping An relative to the HSAHP Index is now at its narrowest level in a decade, indicating a possible shift in market dynamics. Notably, there has been a decrease in the shareholding of Ping An Insurance Group through Northbound Connect, while the shareholding of Ping An Insurance (H) via Southbound Connect has been steadily increasing.

A look at Ping An Insurance (H) Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Analysts are optimistic about the long-term prospects of Ping An Insurance (H), with the company scoring highly in both value and dividend factors. The robust scores indicate that Ping An Insurance is considered to be strong in terms of its financial health and ability to provide consistent returns to investors. However, the company’s growth and resilience scores are moderate, suggesting that there may be room for improvement in these areas. Similarly, Ping An Insurance’s momentum score is relatively low, indicating that the company may be facing challenges in terms of market performance.

Ping An Insurance (Group) Company of China Limited offers a range of insurance services in China, including property, casualty, and life insurance, as well as financial services. The company’s strong focus on value and dividends positions it well for long-term success, although improvements in growth, resilience, and momentum could further enhance its overall performance in the market.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma